Qube Research & Technologies Ltd - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$127
-99.9%
100
-99.6%
0.00%
-100.0%
Q2 2021$122,000
+40.2%
23,079
-12.3%
0.00%0.0%
Q4 2020$87,000
+58.2%
26,327
+59.4%
0.00%0.0%
Q3 2020$55,000
-30.4%
16,517
-29.5%
0.00%0.0%
Q2 2020$79,00023,4210.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders